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The aim was to study whether different strains of
Coxsackievirus B4 (CBV-4) are able to infect hu-
man pancreatic islet cells in vitro and cause morpho-
logical and functional damages. Isolated islets
maintained in tissue culture were infected with
five well- characterised strains of CBV-4. Aliquots
of the culture medium were analysed with regard
to virus replication and insulin content. Infected
and uninfected islets were examined by light mi-
croscopy to determine the degree of virus-induced
cytopathic effect (CPE). The results showed that
the islet cells were susceptible to infection by all
the strains of CBV-4 although the outcome of the
infection differed. The virus titres obtained at 48
and 72 hours post infection differed significantly
between all the CBV-4 strains (p<0.001), indicat-
ing different ability to replicate in islet cells. Pro-
nounced to weak CPE, which was partly due to
the origin (donor) of the islets, was induced by
four of the five CBV-4 strains. One strain (VD2921)
replicated without causing CPE despite high
virus titres. One (V89-4557) of the CBV-4 strains
always revealed pronounced CPE. Infection by
this strain also caused functional impairment that
significantly affected insulin response to high glu-
cose at 48 hours post infection (p< 0.001). Replication
of another CBV-4 strain (JVB) in the islet cells
significantly increased the release of insulin com-
pared to non-infected control cells (p<0.001) indi-
cating damage of the -cells leading to leakage of
insulin.
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INTRODUCTION
There is much evidence to suggest that viral
infections are of etiologic significance for the
development of insulin-dependent diabetes mel-
litus (IDDM). E1’21 The congenital rubella syn-
drome is a well-documented cause of IDDM, E3" 4]
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and epidemiological studies have linked out-
breaks of mumps with clusters of IDDM
cases. E41 There is accumulating evidence that
also enteroviruses, especially Coxsackie B
viruses (CBV), are of etiologic significance in
this context. E2"sl Higher frequencies of neutra-
lising antibodies against CBV have been seen
in IDDM patients compared with healthy con-
trols. CBV-IgM, CBV-derived RNA, and IgM
antibodies against other enteroviruses were
found in higher frequencies in newly diag-
nosed patients than in controls,t6-111 More direct
evidence has been obtained from isolation of
CBV, capable of causing diabetes in mice, from
the pancreas of a few patients with acute onset
IDDM. [12,13]
It has been suggested that induction of IDDM
by CBV may reflect persistent viral infections,
which initiate autoimmune mechanisms direc-
ted against the pancreatic Beta-cells.14 Auto-
immunity against these cells may result from
viral antigens sharing conformational or struc-
tural features with Beta-cell autoantigens, which
leads to a breakdown of immunologic tolerance.
Molecular similarities between the non-structur-
al P2C protein of CBV and islet GAD65
(glutamic acid decarboxylase) have been demon-
strated.1s’161 Alternatively, bacterial toxins or
human endogenous retroviruses may act as
superantigens that induce the formation of
autoreactive T-cell clones directed against the
Beta-cells.t171 This view, however, has been
strongly disputed in more recent studies.E18
There is also the recently proposed possibility
that CBV infection of islet cells causes the re-
lease of sequestered islet antigens resulting in
stimulation of resting autoreactive T-cells and
inflammatory Beta-cell damage,t19
Although CBV may thus be an exogenous
factor of importance for the development of
IDDM, there is still a considerable lack of
knowledge as to the mechanisms involved.
Animal models are not always representative
of the clinical situation as exemplified in
previous studies indicating that human t-cells
are much more resistant to t-cytotoxins and
cytokine-induced cell damage than rodent t-
cells I201 Experiments at the cellular levels have
been hampered by a limited access to isolated
human islets. It has been shown that the tropism
of different strains of CBV-4 differs, e.g., not all
strains can bind to and replicate in t-cells from
mice. I21"22] The present study is an attempt to
test the hypothesis that some strains of CBV-4
are not able to infect human islet cells causing
morphological and functional damage to these
cells. For this purpose we have studied the
interactions between five well-defined strains of
CBV-4 and isolated human islets in vitro with
respect to virus replication, insulin release in
response to glucose and morphological signs of
cellular destruction.
MATERIALS AND METHODS
Preparation and Culture of Isolated
Human Islets
Human pancreata were excised from 32 heart-
beating organ donors aged 41 + 2 years (range
15-63 years; 18 men, 14 women) and trans-
ported to the Central Unit of Beta-Cell Trans-
plant, Brussels, where islet isolation was
performed as previously described.231 Samples
of the isolated islets were examined by elec-
tron microscopy and by light microscopy after
immunocytochemical staining for insulin and
glucagon. There were less than 7% dead cells
(6.2 4-0.7%) and virtually no exocrine cells. The
prevalence of insulin positive cells in the iso-
lated islets was 55 4- 2% and that of glucagon
positive cells 15 4- 3%. The insulin content was
1.51 4-0.14tg/btg islet DNA. The islets were
cultured in Brussels for 13 4- 1 days (range 2-
32) before being sent by air to Uppsala, Sweden.
After arrival in Uppsala the islets were immedi-
ately suspended in groups of 50-150 islets/dish
in 5mL RPMI 1640 containing 5.5mM glucose
and supplemented with 10% foetal calf serum,EFFECTS OF VIRUS REPLICATION 167
benzyl penicillin (100U/mL) and streptomycin
(0.1 mg/mL).
[241
Viruses
Five strains of CBV serotype 4 (CBV-4) were
used. Three of them, namely V89-4557, VD2921
and V345, were plaque-purified after isolation
from patients suffering from aseptic meningitis.
The fourth strain, CBV-4-E2, was kindly pro-
vided by Dr. Tapani Hovi, National Public
Health Institute, Helsinki, Finland, and has
previously been found to be diabetogenic in
mice. I251 This strain was derived from the boy
Edvards. The fifth CBV-4 strain, JVB, generally
considered to be the prototype of CBV-4, was
obtained from ATCC (American Type Culture
Collection). Neutralisation tests were used to
confirm the serotype of the viruses before the
inoculation of the islets cells. Poliovirus sero-
type 1 (PV-1), strain Sabin, was used for com-
parative purposes and was also obtained from
ATCC.
Virus Replication and Cytopathic
Effect (CPE)
Studies of replication of the CBV-4 and PV-1
strains in isolated islets were performed either
without changes of culture medium during the
first seven days, or before changes of culture
medium at 24h intervals for measurements of
insulin release (see below). Islets were inocu-
lated at 37C with 103-104 tissue culture
infectious doses 50 (TCID50) per dish. In the
studies without medium changes each virus was
tested for replication in three to five separate
islet preparations. When islets were inoculated
with the strains V89-4557, VD2921, V345 or PV-
1, the numbers of islets were 60-100/well
(mean 80), while they were 20-35/well (mean
25) in the studies with CBV-4-E2 and JBV. Each
islet consisted of about 1,000 cells. To be able to
show replication in this very small number of
cells (20-35 islets) we included a negative
control consisting of the virus and the culture
medium without any cells. After allowing the
virus to attach for 30-60 min at 37C, the islets
were resuspended in fresh RPMI 1640 supple-
mented as described above. The islets were
examined each day in a microscope for virus-
induced morphological changes, i.e., cytopathic
effect (CPE), which was ranked from 0 to 4 (0,
no CPE compared to the uninfected control;
1 + weak changes: 5-25% of the islets were dis-
rupted; 2 +, weak to moderate changes: 25-50%
of the islet was disrupted; 3 /, severe disruption
of the islets: 50-90% of the islet was disrupted;
4+, the islets were totally disrupted resulting
in. a cell suspension). Infected islets showing a
degree of CPE of 3-4 were stained with 0.2%
trypanblue to estimate the number of dead
cells. In the study of insulin response, where
each strain was tested in 5-10 separate islet
preparations, samples of culture media were
withdrawn every day for assays of virus. This
was also done from islet cultures in which
the medium was changed at 24h intervals.
The assays of virus replication were performed
by TCID50 titrations on Green Monkey Kidney
(GMK) cells.
Measurements of Insulin Release
Groups of 20-100 isolated islets were sus-
pended in 5mL tissue culture medium and
infected with each of the CBV-4 strains or with
PV-1 as described above. For each donor a
group of non-infected islets served as control.
After the initial 24h culture period the me-
dium was changed and the islets maintained
for another 24h at 5.5raM glucose. Aliquots
of the culture medium were removed and
frozen at -20C for later insulin assays. The
culture medium was changed and fresh culture
medium added so that wells containing infected
or control islets were maintained at either
5.5 or 16.5mM glucose for the following 24h,168 G. FRISK AND H. DIDERHOLM
new aliquots were taken for insulin assay. After
a final change of culture medium all islets
were again cultured at 5.5mM glucose for 24 h
and samples taken for insulin assays. They
were performed with Pharmacia Insulin RIA
100 Kit (Pharmacia & Upjohn Diagnostics,
Uppsala, Sweden) using a human insulin stand-
ard. The detection limit for this assay is
< 2tU/mL and the precision within an assay
5.7% according to the manufacturer.
Statistical Analyses
Data presented are means +SEM each islet
preparation, i.e., islets obtained from one donor,
was considered as one individual observation.
All results were based on observations from at
least five donors. A P-value of < 0.05 was con-
sidered significant. Rates of insulin release (tU
islet/24h) from infected and control islets
including calculated differences and ratios,
have been computed using descriptive statistics.
Wilcoxson’s signed rank test was used to
compare virus infected and control islets with
respect to value obtained at 5.5mM glucose at
72h post infection (pi), values obtained at
16.5mM after 72h pi, differences between val-
ues obtained at 5.5 and 16.5mM after 72h,
values at 5.5mM after 96h, and differences
between values obtained at 16.5mM after 72h
and those obtained at 5.5mM after 96 h. The
Kruskal-Wallis’ test was used to assess whether
the six different viruses differed at 16.5mM
after 72h with respect to: (a) the infected islet
value; (b) the difference between the infected
and the control islet value. It is of note that
the Kruskal-Wallis’test is based on the assum-
ption of independent groups, which is not
entirely fulfilled as islets from one and the
same donor have been used to test the effects
of several virus strains. This deviation was,
however, regarded as insignificant for the out-
come. The hypothesis of no difference in titre
levels between the six viruses was tested using
Kruskal-Wallis’test with respect to values
obtained at 72 h pi, values obtained at 96 h pi and
difference between values obtained at 96hpi
and 72 h pi.
RESULTS
Virus Replication in Islet Cells
Over Seven Days
As observed in Figure 1A, the titers (means
4-SEM) of the CBV-4 strains V89-4557 and VD
2921, and the PV-1 show that these strains
replicated well in the islet cells (titre increase
102 105/0.2mL/80 islets). Also the strains CBV-
4-E2 and JVB replicated in the islet cells,
although the titre increases were only 105/
0.2mL/25 islets. The negative control showed
during the same time a 102/0.2mL decrease
in virus titre. The different replication rates
observed with the CBV-4-E2 and JBV strains,
may partly reflect the lower islet numbers used
in these experiments. Interestingly the JVB
strain did not replicate in islets obtained from
one donor (H1 205), suggesting variability in
the susceptibility to the virus. The strain V345
replicated at varying rates in islets obtained
from different donors (Fig. 1B). In two experi-
ments there was only a limited production of
this strain. The third experiment showed a clear
production of virus, although at a slower rate
than the other strains.
Virus Replication in the Experiments
for Insulin Release Determinations
Virus replication was also assessed in the insulin
release experiments, in which culture medium
was changed every 24thh for up to 96h pi
(Tab. I). At 48 h pi the TCID50 titres of each of the
five CBV-4 strains and the PV-1 strain were
consistently increased above those at 2hpi.
After an additional 48 h-period, and another
two changes of culture medium, the titres were
even higher for the CBV-4 strains V89-4557,
VD2921 and V345, and for the PV-1 strain. The2 3 4
Days
JVB inact
E2 inact
Polio-1
E2
JVB
1 2 3 4 5 6 10 11 12 13 14 15
Days
FIGURE A: Virus titres (means + SEM) in the culture medium of infected human islets. Aliquots of the culture medium
were withdrawn every day for seven days and the virus titres were obtained by using the Tissue Culture Infectious Doses0
(TCID50) titration method. The CBV-4 strains used were V89-4557, VD2921, JVB, CBV-4-E2 and PV-1. As a negative control for
the CBV-4 strains CBV-4-E2 and JVB TCIDs0 titrations were performed on aliquots from culture medium from wells not
containing any cells. B: Virus titers in the culture medium of three different islets preparations (A HI 110, HI 115 and @ HI
117) (three diffferent donors) infected with the CBV-4 strain V345. Aliquots of the culture medium were withdrawn every day
for seven days and virus titres were obtained by using the TCID50 titration method. The infection by this CBV-4 strain did not
cause total cytopathic effect (CPE) (not shown).170 G. FRISK AND H. DIDERHOLM
TCIDs0 titres for the CBV-4 strains JVB and CBV-
4-E2 were lower at 96 h pi compared to those
obtained at 48 h pi. The Kruskal-Wallis’test
showed that the titre levels differed between the
strains at 72 h pi (p < 0.001), the values obtained
at 96 h pi (p < 0.001), and the difference between
TABLE Virus titres (mean q-SEM)obtained in the culture medium of the infected islets by the use of Tissue Culture
Infectious Doses0 (TCIDs0) titration method in experiments where the culture media were changed at 24, 48 and 72 hours post
infection (pi). Four different strains of Coxsackievirus serotype B4 (CBV-4) and one strain of poliovirus serotype I (PV-1) were
used and virus titers are presented as 10-log. Mean values of the virus induced cytopathic effect (CPE) on the infected islets at
the same time points pi as the changes of culture media were performed. For each strain five to ten observations were done
Time post infection
Virus 2 h 48 h 96 h
strains n TCIDs0titer CPE TCIDs0titer CPE TCIDs0titer CPE
V89-4557 10 1.7 4- 1.3 0.0 2.6 + 1.5" 1.1 4.0 + 1.1 2.1
VD2921 7 0.9 + 0.9 0.0 1.2 4- 1.0" 0.0 3.3 4- 1.3 0.0
V345 5 0.7 4- 0.1 0.0 1.4 4- 1.6" 0.5 2.3 4- 1.5 1.5
CBV-4-E2 6 3.2 4- 0.1 0.0 3.5 4- 0.1" 0.0 2.3 4- 0.1 1.0
JVB 5 3.3 4- 0.0 0.0 3.6 4- 0.2* 0.3 2.9 4- 0.6 1.8
PV-1 6 0.5 4- 0.2 0.0 2.6 4- 1.7" 1.2 3.3 4- 1.3 2.1 --
Number of infectious doses per 0.2mL culture medium.
*= Significant differences between virus titers obtained at 2 h pi and titers obtained at 48 h pi, and, in addition, significant
differences between the strains at 48h pi.
1,5
0,5
0
0 2 3 4 5 6 7 8
Days
FIGURE 2 Mean values (3-5 observations) of the degree of cytopathic effect (CPE) seen in the infected human islets and islet
cells, cultured in RPMI 1640 supplemented with foetal bovine serum, under a light microscope every day for seven days. The
degree of CPE was estimated and given a score ranging from 0 to 4 (0 no CPE compared to the uninfected control, 2, 25-50% of
the islet was disrupted, 3, 50-90% of the islet was disrupted and 4 the islet were totally disrupted resulting in a cell
suspenstion) (B V89-457, A VD2921, x JVB, CBV-4-E2, and PV-1) compared to non-infected control islets.EFFECTS OF VIRUS REPLICATION 171
values obtained at 96hpi and the values
obtained at 72h pi (p < 0.0001). All the strains
used varied considerably with regard to virus
titre and the time of a replication cycle with the
origin of the islets cells. This may partly be
explained by the different degree of expression
of specific virus receptors and to some extent to
different conditions of the islets due to different
length of the culturing of the islets before
infection (6-36 days),
Morphology of the Islets
The viruses V89-4557 and PV-1 induced
strong CPE (4+) leading to total disruption
of the islets (resulting in a cell suspension) after
seven days (Tab. I, Figs. 2 and 3B). Staining
of the cell suspension with 0.2% trypanblue
revealed that approximately 70-90% (3+) of
the islet cells were dead at seven days pi. The
strain VD2921 revealed no CPE and conse-
quently the islets infected with this strain were
not stained. Even when islet infected with this
strain were followed for up to 26 days they did
not show any morphological changes compared
with the control islets although the virus
continued to replicate in the islet cells (Fig. 3A).
The strains V345, CBV-4-E2 and JVB were
less cytolytic (2-2.5+) than V89-4557 (4+)
and PV-1 (4 +) and they did not totally disrupt
the islets during an observation period of seven
days.
Insulin Release and Insulin Response
to High Glucose
For each virus strain control values were derived
from the same islet population (same donor) as
the infected islets in order to make possible
comparisons between infected and non-infected
islets (Tab. II). Despite this, the data on the rates
of insulin release in some groups showed rather
large variations between individual observa-
tions as evidenced by the large standard errors
of the means.
A
FIGURE 3 A: Islets infected with the CBV-4 strain VD2921
and non-infected islets cultured in RPMI 1640 supplemented
with 10% foetal bovine serum revealed no cytopathic effect
(CPE) at seven days postinfection (pi). In Figure 3A shown
islets infected with the CBV-4 strain VD2921 at seven days pi.
B: Islets infected with the CBV-4 strain V89-4557 cultured in
RMPI 1640 supplemented with 10% foetal bovine serum for
five days revealed a strong CPE (3-4). It is possible that the
use of 10% FCS might decrease the virus titre but it is
appropriate for studying the insulin release in response to
high glucose.
The insulin release in the second 24 h-period
(48h pi) was the same from the infected islets
as from the control islets. In the third culture
period (72h pi) at 5.5mM glucose, there was a172 G. FRISK AND H. DIDERHOLM
TABLE II Insulin release in the culture media from islets infected with different CBV-4 strains and PV-1 and from control
islets. Insulin content was measured after 72 hours post infection(pi). The islets have from 48 to 72 hours pi been cultured in
media containing 5.5mM or 16.5mM glucose. Insulin content of the media was also measured 96 hours pi. The culturing
condition from 72 to 96 hours pi was in media containing 5.5mM glucose
Insulin release*/islet/24hour
Virus 72 hours 96hours
strain n 5.5mM 16.5mM 5.5mM 5.5mM
V89-4557 10 131 4- 36 338 4- 77* 37 4- 12 72 4- 10
Controls 10 148 4- 36 602 4- 77 69 4- 22 123 4- 28
VD2921 7 110 4- 41 406 4- 94 109 4- 16 96 4- 19
Controls 7 85 4- 32 479 4- 72 39 4- 16 58 4- 9
V345 5 80 4- 20 515 4- 177 54 4- 22 61 4- 18
Controls 5 63 4- 4 601 4- 73 36 4- 10 61 4- 18
CBV-4-E2 6 115 4- 80 480 4- 325 99 4- 28 176 4- 166
Controls 6 107 4- 36 638 4- 243 56 4- 17 49 4- 48
JVB 7 333 4- 126 626 4- 187 239 4- 122" 299 4- 36*
Controls 7 85 4- 30 672 4- 195 50 4- 13 113 4- 36
PV-1 6 184 4- 76 314 4- 71" 17 4- 11 58 4- 31
Controls 6 104 4- 27 647 4- 45 64 4- 31 77 4- 35
#U insulin/islet/24 hours.
Glucose concentration in the culture media. v Continuously cultured in 5.5mM glucose.
Cultured in 16.5 mM glucose for 24 hours and then in 5.5mM glucose for additional 24 hours.
P < 0.001 against the respective controls.
modest, although not significant, increase in the
rate of insulin release in islets infected with
either the JVB strain of CBV-4 or the PV-1. The
simultaneous culture of islets at the 16.5mM
glucose medium showed, however, marked
differences between the virus strains with
respect to the ability of glucose to stimulate the
rates of insulin release. There was thus a
diminished insulin release in response to
16.5mM glucose after infection of islets with
either V89-4557 or PV-1 (P < 0.05 vs. controls).
The insulin release in islets infected with the JVB
strain, cultured at low glucose, was significantly
higher than the rate of the controls indicating
that a leakage of insulin could be detected as
early as 72h pi. The increase in the rate of insulin
release after exposure of islets to 16.5mM
glucose as compared to 5.5mM was 6 12 times
in the control islets (P < 0.05 for all control
groups). This increase was markedly diminished
(to < 4 times) in islets infected with either V89-
4557, JVB or PV-1. The low increase in the latter
group reflected, however, an increased insulin
release also in the infected islets cultured in
parallel with 5.5mM glucose.
In the last culture period (96 h pi), the rates of
insulin release of islets cultured at 16.5mM
glucose, with one exception, returned to levels
comparable to those shown in islets maintained
at 5.5mM glucose throughout the culture peri-
od. Only islets infected with the JVB strain
showed a lasting high rate of insulin release also
after return to a low-glucose (5.5mM) culture
medium. It is of note that islets infected with this
strain also showed an increased rate of insulin
release at 72 h pi at 5.5mM glucose.
DISCUSSION
The human islets used in the present study
originated from pancreata excised from heart-
beating donors, who differed both with regardEFFECTS OF VIRUS REPLICATION 173
to age, sex and genetic background. Variations
between individual donors could therefore be
expected, even if the islets, after being isolated,
were maintained in culture media with uniform
composition. Differences were indeed seen both
with respect to virus multiplication in the islet
cells, the CPE and the insulin response to
glucose. Although the inherent heterogeneity
of the islet cells justifies a cautious interpretation
of the data, some conclusions can nevertheless
be drawn.
First, the present observations indicate that
each of the CBV-4 strains had a tropism but to
various extent for the human islet cells since
they all replicated in the human islets. Although
in a few islet preparations, epithelial-like cell
could be seen at the bottom of some wells after a
few days of culturing, these cells never revealed
any CPE and the virus titres were unaffected.
This indicates that all viral replication took place
in the islet cells. The question whether the t-
cells were infected with the VD2921 strain can
not be clarified since there were no CPE and no
effect on insulin release after culture in high
glucose. However, the CBV-4 strains V89-4557
and JVB and PV-1 significantly affected the in-
sulin release in some way, indicating that virus
replication took place in the t-cells. The different
replication rate of the virus strains depended
both on the strain itself and on the properties
of the target donor cells, possibly indicating
a disparity in the expression of cell surface
molecules acting as virus receptors. The impor-
tance of the latter was particularly well illu-
strated by the TCID50 titres of the V345 strain,
which showed marked differences between
different donors. To what extent this reflected
individual differences between the expression
of virus receptors on the islet cells, differences
in islet cell viability or other factors remains to
be established.
Second, all but one of the viruses caused CPE
on the human islets ranging from mediocre
(2+) to pronounced (4+) at seven days pi.
The exception was islets infected with VD2921,
which caused no CPE despite ongoing viral
replication for up to 26 days pi. All the other
strains caused at least some degree of lysis
within the first four days. We therefore decided
to carry out the measurements of insulin release
from the infected islets cells within this time of
culture in order to obtain results which reflected
a true insulin response to a high glucose
concentration rather than a mere leakage of
insulin from lysed t-cells. Our data provide a
fair representation of functionally surviving
insulin producing cells for 96hpi when the
islets were infected with the all of the CBV-4
strains except the JVB strain. A final culture
in low glucose to as certain that the islets
responded with a decrease in insulin release
revealed that islets infected with all of the virus
strains except JVB, returned to basal rates. Islets
infected with the JVB strain continued to release
significantly higher levels of insulin than the
control islets, indicating that infection with this.
strain has in some way affected the t-cells,
resulting in a leakage of insulin. It has earlier
been shown in mouse islets infected with an
mouse pancreas-adapted strain of CBV-4 in-
duced leakage of insulin when cultured in basal
glucose concentrations.26 It has been found that
there is a selective "shut off" of the proinsulin
synthesis by CBV-4. [27] In islets infected with
V89-4557 and PV-1, almost all cells were lysed
during a seven day period as shown by the
trypanblue staining of the islets cells. This
subtype of type! diabetes mellitus characterised
by a rapid onset and an absence of diabetes-
related antibodies has been reported by Imaga-
wa et al. 2000. I281 Poliovirus serotype 1 (PV-1)
belongs to the enterovirus genus and it has been
associated with diabetes in a man following an
infection,29 it also showed tropism for the hu-
man islet cells resulting in lysis and decreased
insulin response to glucose in this study.
However, epidemiological data linking polio
to IDDM are scarce and still insufficient to ex-
clude a positive association between these two
conditions.174 G. FRISK AND H. DIDERHOLM
In conclusion, all the virus strains used could
replicate in human islet cells. To our knowledge
this is the first time it has been shown that
different strains of a serotype of Coxsackie B can
differ in their replication pattern in human islet
cells. The outcome of the infection differed.
Infection with three of the strains, two CBV-4
strains and PV-1, affected the insulin release
significantly compared with controls, indicating
replication of virus in the t-cells. One of the
CBV-4 strains that was able to replicate in islet
cells without causing CPE might in vivo initiate
an autoimmune response due to its persistence
in the islets cells. Persistently infected cells
may show injured cell metabolism even if the
infection is not lethal. When only a part of
the islet cells is killed immediately and the
functional capacity of the remaining cells is
almost unaffected, an autoimmunity, perhaps
by exposing intracellular proteins, might initiate
the process leading to IDDM, e.g., the strains
that only caused mediocre CPE might also be
diabetogenic.
Acknowledgements
The authors are grateful to Dr. Decio Eizirik and
Dr. Claes Hellerstr6m for advice and encourage-
ment during the course of this work. We are al-
so grateful for the technical assistance of Mrs.
Marianne Ericsson, to Dr. Tapani Hovi, National
Public Health Institute, Helsinki, Finland, for
kindly providing the CBV-4-E2 strain. The
experiments, were supported by grants from
the European Community (BMH4-CT-95-1561,
BMH4-CT98-3952), the Swedish Diabetes Asso-
ciation, Gillbergska foundation, Novo Nordisk
foundation and the Medical Research Council
(K97-12XC-12445-01A, K98-12XC-12445-02B).
Re[erences
[1] Szopa, T. M., Titchener, P. A., Portwood, N. D. and
Taylor, K. W. (1993). Diabetes mellitus due to viruses-
some recent developments. Diabetologia, 36, 687-695.
[2] Yoon, J. W., Environmental factors in the pathogenesis
of insulin-dependent diabetes mellitus. In: Pickup, J. C.
and Williams, G. (Eds.), Textbook of diabetes mellitus.
Blackwell Science Ltd., London, 1997, pp. 14.1-14.14.
[3] Ginsberg-Fellner, F., Witt, M. E. and Yagihaski, S.
(1984). Congenital rubella-syndrome as a model for
type (insulin-dependent) diabetes mellitus: Increased
prevalence of islet cell surface antibodies. Diabetologia,
27, 87- 89.
[4] Gamble, D. R. (1980). Relation of antecedent illness to
development of diabetes in children. British Medical
Journal, 2, 99-101.
[5] Hy6ty, H., Hiltunen, M., Knip, M., Laakonnen
V/ih/isalo, M., Karjalainen, J., Koskela, P., Roivainen,
M., Leinikki, P., Hovi, T. and kerblom, H. K. (1995).
Childhood Diabetes in Finland Study Group. A
prospective study of the role of Coxsackie B and other
enterovirus infections in the pathogenesis of IDDM.
Diabetes, 44, 652-657.
[6] King, M. L., Shaikh, A., Bidwell, D., Voller, A.
and Banatvala, J. E. (1985). Coxsackie-B-specific
IgM responses in children with insulin-dependent
(juvenile-onset; type 1) diabetes mellitus. Lancet, 1,
1397-1399.
[7] Frisk, G., Fohlman, J., Kobbah, M., Ewald, U., Tuvemo,
T., Diderholm, H. and Friman, G. (1985). High
frequency of Coxsackie-B-virus-specific IgM in chil-
dren developing Type diabetes during a period of
high diabetes morbidity. Journal of Medical Virology,
17, 219- 227.
[8] Frisk, G., Nilsson, E., Tuvemo, T., Friman, G. and
Diderholm, H. (1992). The possible role of Coxsackie
A and Echo viruses in the pathogenesis of Type 1
diabetes mellitus studied by IgM analysis. Journal of
Infectious Diseases, 24, 13-22.
[9] Frisk, G. and Diderholm, H. (1997). Antibody re-
sponses to different strains of Coxsackievirus B4 in
children with newly-diagnosed Type diabetes melli-
tus. Journal of Infection, 34, 205-210.
[10] Clements, G. B., Galbraith, D. N. and Taylor, K. W.
(1995). Coxsackie B virus infection and onset of
childhood diabetes. Lancet, 346, 221- 223.
[11] Andr6oletti, L., Hober, D., Hober-Vandenberghe,
C., Belaich, S., Vantyghem, M. C., Lefebvre, J. and
Wattr6, P. (1997). Detection of Coxsackie B virus
RNA sequences in whole blood samples from adult
patients at the onset of Type 1 diabetes mellitus.
Journal of Medical Virology, 52, 121-127.
[12] Yoon, J.-W., Austin, M., Onodera, T. and Notkins, A. L.
(1979). Isolation of a virus from the pancreas of a
child with diabetic ketoacidosis. New England Journal
Medicine, 300, 1173-1179.
[13] Champsaur, H. F., Bottazzo, G. F., Bertrams, J., Assan,
R. and Bach, C. (1982). Virologic, immunologic, and
gentic factors in insulin-dependent diabetes mellitus.
Journal of Pediatrics, 100, 15-20.
[14] Yoon, J. W., Viruses as triggering agents of insulin-
dependent diabetes mellitus. In: Leslie RDG (Ed.),
The Causes of Diabetes, London: John Whiley & Sons,
1993, pp. 83 103.
[15] Hou, J., Said, C., Franchi, D., Dockstader, P. and
Chatterjee, N. K. (1994). Antibodies to glutamic acid
decarboxylate and P2-C peptides in sera from Cox-
sackie-virus B-4 infected mice and IDDM patients.
Diabetes, 43, 1260-1266.
[161 L6nnrot, M., Hy6ty, H., Kniop, M., Roivainen, M.,
Kulmala, P., Leinikki, P. and Akerblom, H. K. (1996).
Childhood Diabetes in Finland Study Group. AntibodyEFFECTS OF VIRUS REPLICATION 175
cross-reactivity induced by the homologous regions in
glutamic acid decarboxylase (GAD65) and 2C protein
of Coxsackievirus B4. Clinical Experimental Immunology,
104, 389 405.
[17] Conrad, B., Weissmahr, R. N., B6ni, J. and Mach, B.
(1997). A human endogenous retroviral superantigen
as candidate autoimmune gene in Type diabetes.
Cell, 90, 303- 313.
[18] Kim, A., Jun, H. S., Wong, L., Stephure, D., Pacaud, D.,
Trussell, R. A. and Yoon, J. W. (1999). Human
endogenous retrovirus with a high genomic sequence
homology with IDDMK (1,2) is not specific for Type
(insulin-dependent) diabetic patients but ubiquitous.
Diabetologia, 42, 413 418.
[19] Horwitz, M. S., Bradley, L. M., Harbertson, J., Krahl, T.,
Lee, J. and Sarvetnick, N. (1998). Diabetes induced by
Coxsackie virus: Initiation by bystander damage and
not molecular mimicry. Nature Medicine, 4, 781- 785.
[20] Eizirik, D. L., Pipeleers, D. G., Ling, Z., Welsh, N.,
Hellerstr6m, C. and Andersson, A., Major species
differences between humans and rodents in the
susceptibility to pancreatic-cell injury. Proceedings of
National Academic Science, 1994, 91, 9253-56.
[21] Titchener, P. A., Genetic studies on Coxsackie B4 tissue
tropism. Ph.D. Thesis, University of Reading, 1991
Reading UK.
[22] Hartig, P. C., Madge, G. E. and Webb, S. R. (1983).
Diversity within a human-isolate of Coxsackie B4:
relationship to viral-induced diabetes. Journal of Medi-
cal Virology, 11, 23-30.
[23] Keymeulen, B., Ling, Z., Gorus, F. K., Delvaux, G.,
Bouwens, L., Grupping, A., Hendrieck, C., Pipeleers-
Marichal, M., Van Schravendijk, C., Salmela, K. and
Pipeleers, D. G. (1998). Implantation of standardized
beta-cell grafts in liver segment of IDDM patients:graft
and recipients characteristics in two cases of insulin-
independence under maintenance immunosuppres-
sion for prior kidney graft. Diabetologia, 41, 452-459.
[24] Eizirik, D. L., Korbutt, G. S. and Hellerstr6m, C. (1992).
Prolonged exposure of human pancreatic islets to high
glucose concentrations in vitro impairs the beta-cell
function. Journal of Clinical Investigation, 90, 1263-1268.
[25] Yoon, J. W., Ausin, M., Onodera, T. and Norkins, A. L.
(1979). Isolation of a virus from the pancreas of a child
with diabetic ketoacidosis. New England Journal of
Medicine, 24, 1173-1179.
[26] Szopa, T. M., Gamble, D. R. and Taylor, W. (1986).
Coxsackie B4 virus induces short-term changes in the
metabolic functions of mouse pancreatic islets in vitro.
Cell Biochemistry and Function, 4, 181-187.
[27] Poortwood, N. D. and Taylor, K. W. (1990). Coxsackie
B4 virus-induced changes in mouse pancreatic tg-cell
m-RNAs. Biochm. Soc. Trans., 18, 1264.
[28] Inagawa, A., Hanafusa, T., Miyagawa, J. and
Matsuzawa, Y. (2000). A novel subtype of Type 1
diabetes mellitus characterized by a rapid noset and
an absence of diabetes-related antibodies. New England
Journal of Medicine, 342, 301- 307.
[29] John, H. J. (1934). The diabetic child. Ethiologic factors.
Ann. Internal Medicine, 8, 198-213.